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Recent discoveries demonstrate a critical role for circadian rhythms and sleep in immune system
homeostasis. Both innate and adaptive immune responses — ranging from leukocyte mobilization,
trafficking, and chemotaxis to cytokine release and T cell differentiation —are mediated in a
time of day–dependent manner. The National Institutes of Health (NIH) recently sponsored
an interdisciplinary workshop, “Sleep Insufficiency, Circadian Misalignment, and the Immune
Response,” to highlight new research linking sleep and circadian biology to immune function and
to identify areas of high translational potential. This Review summarizes topics discussed and
highlights immediate opportunities for delineating clinically relevant connections among biological
rhythms, sleep, and immune regulation.
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Introduction
Circadian rhythms are daily variations in behavior and biological activity that stem from an intrinsic ability
of organisms to align themselves with the environmental 24-hour light/dark cycle. These rhythms originate from an internal biological clock that drives many aspects of human physiology, including the sleepwake cycle and daily variations in blood pressure, body temperature, and cortisol (1). A growing body
of epidemiological evidence demonstrates an association between altering circadian timing through shift
work or frequent time zone travel and increased rates of cardiovascular disorders, metabolic syndrome, and
cancer (2–4). Clinical aspects of disease such as pain perception, asthma exacerbations, and myocardial
infarctions are more common at certain times of day or night (5, 6). The discovery of the genetic basis for
the circadian clock in the 1980s and 1990s has ushered in a new era in which long-appreciated circadian
rhythms in physiology and clinical medicine are being reframed in terms of gene expression, metabolism,
signal transduction, and cellular physiology (7). The translation of circadian discovery into strategies to
improve the prevention and management of disease promises to be transformative, but at present, fundamental research is outpacing clinical application (Figure 1A). Much will depend on research identifying
the critical mechanisms and targets to which circadian rhythm–based therapeutic strategies can be applied.
An emerging example of exciting circadian discovery with potential clinical relevance is the intersection
between circadian function and immune regulation (Figure 1B).
The NIH recently sponsored a workshop entitled “Sleep Insufficiency, Circadian Misalignment, and
the Immune Response” (May 16–17, 2019, Rockville, Maryland, USA). Its aim was to highlight basic
and clinical advances linking sleep and circadian biology to immune dysfunction, thereby stimulating the
application of circadian biology to translational medicine. The Workshop was cosponsored by four NIH
institutes — the National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA),
National Institute of Allergy and Infectious Diseases (NIAID), and National Institute on Alcohol Abuse
and Alcoholism (NIAAA) — reflecting a broad interest and recognizing that circadian and sleep-based
research cuts across traditional academic disciplines. Here, we report the perspective of the Workshop
participants on circadian biology, sleep, and immunity, and review emerging literature that links circadian
rhythms and sleep to specific immune functions. Finally, we highlight future research opportunities as well
as challenges that need to be overcome in order to implement chronotherapy in clinical settings.

Introduction to the molecular circadian clock
Circadian rhythms evolved as organisms were selected for their preparedness for the environmental shifts brought
about by the solar day (8). The molecular model for circadian rhythm generation arose from genetic screens
designed to find mutations that disturb the sleep-wake cycle in model organisms (7). In both flies and mammals,
the key constituents of the molecular circadian clock are either transcription factors or transcription factor regulators (i.e., “clock genes”; Figure 2). At the core of the clock is a heterodimer composed of the proteins BMAL1
and CLOCK (9). This complex stimulates transcription by altering the chromatin landscape around genes containing E-box motifs in their promoters (10). Among the downstream effectors of BMAL1/CLOCK are fellow
clock gene products Per1–3, Cry1/2, NR1D1/2 (also known as REV-ERBα/β, and RORα–γ, whose products
either negatively or positively regulate the core complex (9). Thus, the expression of clock genes oscillates with
roughly a 24-hour periodicity, thereby biochemically representing the solar day. Other downstream effectors of
the molecular clock include master transcription factors, such as the PAR domain basic leucine zipper transcription factor family (DBP, TEF, and HLF) (11), nuclear factor IL-3–regulated (NFIL3, also known as E4BP4)
(12), and the PPAR family (11, 13). Through these clock-controlled genes (CCGs) as well as others, the molecular clock imparts a circadian pattern on gene expression, and by extension protein and metabolite abundance.
Molecular clocks operate in almost all nucleated cells throughout the body, thereby allowing cells to factor timeof-day information into the control of metabolism and other key pathways (14).
The molecular clock contains some special features that are important for its role in regulating the physiology of higher organisms. First, clock proteins and clock genes are subject to numerous forms of biochemical regulation, including acetylation, methylation, phosphorylation, ubiquitination, and sumoylation (15).
Combined with signal transduction through accessory pathways, these modifications impact clock protein
levels and activity, thereby allowing ambient biochemical cues, such as temperature, nutrient status, hormone
levels, and innervation, to synchronize internal cellular time with the external world (16). This phenomenon
is known as entrainment and serves an additional crucial role in creating temporal coherence within organs
by synchronizing parenchymal cells with one another. To harmonize the various biochemical entrainment
insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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Figure 1. Citations in chronotherapy and circadian research are on the rise. (A) Number of 1990–2018 publications found with PubMed searches for “circadian” and “chronotherapy.” (B) Number of 1990–2018 publications found with PubMed searches for “sleep and immunity,” “circadian and immunity,” and
“chronotherapy and immunity.” Chronotherapy is classically defined as the use of circadian information to maximize the therapeutic index of a medical
intervention or to limit the amount of drug needed to achieve a clinical end point by giving it at the optimal time of day. An emerging use of the term is for
the direct targeting of clock gene function to achieve a clinical end point, such as tumor killing (148). Illustrated by Rachel Davidowitz.

cues, mammals require a “master circadian pacemaker” located in the suprachiasmatic nucleus (SCN) of
the hypothalamus. The SCN receives light information from the retina and then projects to other CNS areas
that regulate arousal, autonomic tone, temperature, and hormone secretion (16). Of all the entrainment cues,
light has the largest impact on rest-activity rhythms, and the clocks within SCN neurons are selectively sensitive to light for entrainment. However, because SCN clocks synchronize to changing light cycles faster than
peripheral clocks, and because mistimed feeding or other biochemical cues can compete with SCN pacing in
the periphery (17), it is possible to induce a state of internal desynchronization. This desynchronization is
thought to explain the sequelae of jet lag and night-shift work (18–20). A second key feature of the molecular
clock is that its regulatory influence extends from the microscopic to the macroscopic biological scale. For
example, mutations that alter the periodicity of Per and Cry expression provoke analogous changes to the
periodicity of sleep timing and quality (21–23). A final feature is programmability. While the anatomy of
the molecular clock is largely uniform across tissues, the circadian transcriptomes it generates (i.e., the set
of CCGs exhibiting rhythmic expression) are highly tissue specific and overlap by only about 10% between
organs (24). The remarkable organ specificity of circadian transcriptomes is thought to be a product of cell
type–specific transcription factors and tissue-selective patterns of chromatin accessibility (25, 26). Collectively, the cardinal molecular clock features of entrainment, programmability, and the ability to impact function
at all biological scales enable tissues to harness time-of-day information in the service of their unique physiologic contributions. They also makes it possible for the clock to organize diverse networks of cells around a
common goal, for example, a coordinated immune response.

Clocks and immunity
The current focus on circadian control of immune function was presaged by the observations — first published more than 50 years ago — that circulating lymphocyte counts oscillate on a daily basis in healthy
humans (27) and that the susceptibility to endotoxin depends on the time of day it is administered in
rodents (28). More recent work highlights epidemiological associations between night-shift work (i.e.,
activity and sleep patterns in opposition to the normal day-night pattern) and elevated levels of systemic
inflammatory markers (29, 30). Significantly, all lymphoid organs and immune cell types tested to date
harbor functional clocks (31, 32). Studies using genetic experimental approaches in human cells and mice
suggest a connection between clocks and at least three fundamental immunologic activities.
The best-documented connection between clocks and immune function is the regulation of proinflammatory cytokine secretion. Cytokines are well-known mediators of host responses to infection, trauma, and
immune responses. In endotoxin-stimulated macrophages, the magnitude of TNF-α secretion was found
to vary in a circadian fashion based on the time of endotoxin challenge (31). The current paradigm for
insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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Figure 2. Circadian regulation in mammals. Schematic depicting the currently accepted hierarchal model for circadian rhythm generation. Light information is conveyed by the optic nerve to the SCN, a region of the ventral hypothalamus. There, light entrains clocks within SCN neurons, and this is
ultimately converted by the CNS into pulsatile chemical and neurological cues, which entrain cell-autonomous circadian clocks residing in peripheral cells.
These peripheral clocks impart circadian patterns on gene expression and overall cellular physiology. For simplicity, only the core molecular clock circuitry
is depicted, with positive regulatory proteins labeled green and negative regulators labeled red. However, there are many accessory proteins and metabolic
pathways that can adjust the periodicity and phase of the clock but are not central to rhythm generation (for example, casein kinase 1δ/ε [ref. 23], AMPK
[ref. 149], mTOR [ref. 150], p53 [ref. 151], and SIRT1 [ref. 152]). There are additional molecular clock constituents (not depicted) that in the basal state
appear to have more prominent roles in CNS clocks than clocks in peripheral cells. For example, NPAS2 (a functional homolog of CLOCK) and DEC1/2 provide additional negative feedback to BMAL1/CLOCK (16, 153). Yellow boxes represent E-boxes or ROR-responsive elements (RREs), which are the promoter
motifs recognized by BMAL1/CLOCK or REV-ERB/ROR proteins, respectively. Clock genes and clock-controlled genes (CGs) are represented by green and
purple arrows, respectively. Illustrated by Rachel Davidowitz.

explaining how the clock imparts rhythms to cytokine production involves the ability of clock proteins to
directly transactivate or repress gene expression of key cytokines and chemokines, including CCL2, TNF,
IL-6, and CXCL5 (reviewed in ref. 33). This paradigm also extends to CCGs. For example, in LPS-stimulated macrophages, the clock-controlled transcription factors NFIL3 and DBP impart a circadian rhythm
to IL-12(p40) secretion by alternating their binding to the Il12 promoter throughout the day (34). Thus,
disruption of molecular clock function through light-cycle desynchronization or deletion of Bmal1 or Reverba locks macrophages into a “time of day” wherein inflammatory cytokine secretion is maximized (35,
36). This hypersecretory phenotype is not limited to immune cells but extends to epithelial cells, which are
responsible for initial leukocyte recruitment after infectious and sterile insults (36–38). Interestingly, inflammation appears to feed back on the integrity of the molecular clock. For example, Clock, REV-ERBα,
and BMAL1 protein levels decline rapidly in cells after endotoxin treatment, which is predicted to disrupt
clock function (39–41). Conversely, herpes virus infection stimulates Bmal1 promoter activity, leading to
a corresponding depression in Cry1 and a disruption in the feedback relationships that underlie the clock
(42). Indeed, disruption of clock gene expression appears to be a common outcome of acute infection and
leads to novel rhythms of gene expression characterized by prominent cycling of proinflammatory genes
(37, 43). Some suggest that the circadian clock is itself a kind of innate immune sensor that when disabled
by infection automatically shifts cells to a proinflammatory state. However, during chronic inflammation
or stressors such as shift work, disrupted clocks have been shown to increase the morbidity in response to
infection or sterile insult through excessive inflammation (44–49).
Trafficking of myeloid and lymphocyte subsets in healthy mice and humans is another circadian-regulated immune activity (50–52). Leukocyte trafficking represents the summation of several discrete, individually rhythmic processes (Figure 3), including cell egress from bone marrow (53, 54), leukocyte homing
from the bloodstream to the interstitial space of organs (51, 55), and removal of leukocytes from organs
through phagocytosis or via transit to regional lymph nodes (56, 57). Regardless of cell type, mechanisms
of rhythmic trafficking involve coordinated clock function within the leukocyte and within endothelial cells
lining the vessels of peripheral organs. Together, these clocks align the expression of receptor-ligand pairs
critical for chemoattraction and adhesion to the endothelial surface, thereby facilitating leukocyte recruitinsight.jci.org   https://doi.org/10.1172/jci.insight.131487
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ment (51, 55). Additional levels of control, including adrenergic tone and leukocyte ROS, appear to play a
role in setting the phase of leukocyte trafficking rhythms (51, 52, 58). Interestingly, the critical ligand-receptor interactions needed for leukocyte homing appear to vary depending on the cell type and the destination
organ (55). Altogether, the complexity of leukocyte trafficking makes clear the importance of the clock in
optimizing this critical immune activity.
A third connection between clocks, clock genes, and immune processes is among the least studied:
differentiation and maturation of clinically important leukocyte subsets. For example, the canonical clock
gene Rora is required for the differentiation of type 2 innate lymphoid cells (ILC2s), which play a role in
type II inflammation, allergy, and defense against parasites (59). A splice variant of the clock gene Rorg
(Rorgt) is critical for the development of type 3 innate lymphoid cells (ILC3s), lymphoid tissue inducer (LTi) cells, and the CD4+ T helper cell subset Th17 cells (60–62). Rora is also important for the full
development of Th17 cells (63). ILC3s and Th17 cells are characterized by secretion of IL-17, and both
are implicated in autoimmune diseases. Disruption of molecular clock function leads to aberrant Th17
cell development and renders mice more susceptible to pathology in models of autoimmunity, including
experimental autoimmune encephalomyelitis (EAE), a mouse multiple sclerosis model, and colitis (64, 65).
Interestingly, Rorgt mRNA expression is blocked by melatonin, a hormone with pleiotropic immunomodulatory activity that is secreted in a circadian fashion by the pineal gland (66, 67). Finally, circadian clocks
were recently found to regulate neutrophil maturation (68), which is remarkable given the short life span
(only 1–2 days) of these crucial effector cells. As neutrophils age, they undergo cytoskeletal and cell-adhesive changes that enhance their migration into the interstitial spaces of organs according to a circadian
rhythm (53, 68). These changes are mediated by Bmal1, and loss of this clock gene blocks their efficient
homing to organs (68). The result is that initial innate responses against invading organisms are weakened
in Bmal1-deficient mice, thereby increasing disease severity (68). Clock control of neutrophil maturation
has an additional homeostatic function, as trafficking of aged neutrophils into the bone marrow suppresses
the hematopoietic niches that control the egress of leukocytes in the first place (53). In doing so, rhythmic
neutrophil homing completes a feedback loop that may help to make circadian trafficking patterns for all
hematopoietic types self-sustaining.
Altogether, it is increasingly clear that circadian gating is part of the core programing of the immune
system, and thus, alteration of this regimen is likely to have widespread ramifications for disease pathogenesis. Current evidence draws a direct mechanistic line between the biochemistry of a clock protein, such as
BMAL1, and a discrete immune parameter, like the production of the neutrophil chemoattractant CXCL5
during lung injury (36). Alternatively, the clock may impact immunity by regulating sleep.

Sleep and immunity
Sleep is a basic behavior common to almost all organisms and is defined by a period of relative unresponsiveness to outside stimuli. In humans, sleep can be subdivided into an orderly progression of neurological stages based on EEG patterns that repeat roughly every 90 minutes (69). There is no consensus on
what defines ideal sleep, but total sleep deprivation in rodents is fatal (70). It is still not fully understood
why denying rodents sleep is deadly; however, studies have shown that chronically sleep-deprived animals
exhibit splenic atrophy and polymicrobial bacteremia, suggesting that immune dysfunction may be part of
the dying process (70, 71). In a similar vein, short habitual sleep (<6 hours per night) is statistically associated in humans with reduced life span, increased vulnerability to viral infection, and reduced antibody
titers after vaccination (72–74). Short-term sleep deprivation prior to vaccination appears to negatively
impact antibody titers after influenza vaccination and, at least in rodents, reduces influenza vaccine efficacy
(75–77). Just as sleep impacts immune functions, it appears that certain peripheral immune populations
may affect sleep. For example, chemical or genetic ablation of macrophages affects the architecture of
rebound sleep in sleep-deprived mice (78, 79). Altogether, sleep is connected to an organism’s resilience
against infection, and considerable work has been done in humans and animal models to examine how
sleep deprivation impacts specific immune parameters (80).
The relationship between circadian rhythms and sleep is complex and likely bidirectional. In humans, the
paradigm for sleep timing is a “two-process” model (processes C and S) in which CNS circadian clocks play
a major role. Clocks generate daily oscillations in neurological arousal (process C), which promotes wakefulness and opposes drowsiness that accumulates through sleep debt (process S) (81). Work in Bmal1-deficient
model organisms suggests that clocks may have an additional role in mediating normal sleep architecture (82–
insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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Figure 3. Multilayered circadian control of leukocyte trafficking. Schematic depiction of the circadian regulation of specific leukocyte trafficking steps
(55–57, 68). These include the egress of leukocytes from the bone marrow; adhesion of circulating leukocytes to endothelial cells in the capillary beds of
end organs; and removal of leukocytes from the parenchyma of organs by phagocytosis or by migration to area lymph nodes. Proteins generally important for rhythmic leukocyte trafficking at specific steps in the process are depicted in red. For a comprehensive treatment of cell-specific determinants of
leukocyte trafficking rhythms, see Pick et al. (154). Lymph/Mac, lymphocyte/macrophage. Illustrated by Rachel Davidowitz.

insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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84). While clocks gate sleep, it is also true that short-term sleep disruption can affect circadian regulation in
peripheral tissues such as blood and lung, by either damping the rhythms in CCG expression or altering their
phase (85, 86). Thus, while circadian rhythms and sleep are biologically different phenomena and can be analyzed in isolation using “forced synchronization” protocols in humans (87), it is difficult to perturb one without affecting the other under naturalistic conditions. For physicians, the conflation of circadian rhythms and
sleep during disease dates to Greek antiquity. The writings of Arataeus of Cappadocia on asthma posed the
question of whether asthma exacerbations are more frequent at night because of the time of day or because
patients are typically asleep at night (88). Some pathogens even corrupt the circadian-mediated sleep/wake
cycle to promote disease. For example, Trypanosoma brucei (which causes African sleeping sickness) alters
sleep patterns in afflicted subjects by shortening the periodicity of the molecular circadian clock (89).
Given the interconnectedness of sleep and circadian rhythms, it is understandable that the immune
activities affected by insufficient sleep overlap with those altered by circadian disruption. Experimentally
induced sleep deprivation and short habitual sleep increase proinflammatory cytokine secretion, particularly in males (90, 91). Numbers of circulating neutrophils, NK cells, monocytes, and B cells are increased
by prolonged wakefulness and decreased by recovery sleep, suggesting a role for sleep in regulating leukocyte trafficking (80, 92). Recent work in mice found that sleep fragmentation increases the production of
inflammatory monocytes by the bone marrow and leads to atherosclerosis, an inflammatory pathology
also induced by Bmal1 deficiency (93, 94). Finally, inadequate sleep seems to impair immune effector cell
functions such as NK cell activity, at least in some experimental scenarios (80, 95).
Circadian rhythms and sleep are increasingly seen as important for immune system homeostasis. Disruption of either process can engender a state of inflammation and functional immunocompromise, rendering organisms more vulnerable to disease. Historically, circadian biology, sleep, and immunology have
occupied separate branches of investigation. Consequently, there has been little interdisciplinary research
on these topics. The key point is that circadian rhythm and sleep disruption happen concurrently every
day through the widespread experiences of shift work, nighttime light exposure, and social jet lag, which
is caused by discontinuity between natural sleep-wake schedules and the variations in the social demands
of weekdays versus weekends. Thus, the interface between circadian rhythms, sleep, and immune function
potentially has a wide range of implications for public health and medicine.

Workshop-identified opportunities
The goal of the NIH Workshop was to highlight recent basic and clinical research advances in sleep and
circadian biology linking immune dysfunction to pathobiology, and to foster interdisciplinary conversations that could point toward future research objectives. Following 2 days of presentations and discussions
covering a wide range of disease-based research, the participants developed recommendations on the most
timely and compelling questions in this area. The participants also discussed various challenges for circadian-immune and sleep-immune discovery research to be translated and implemented more effectively.
Adaptive immune response. The highest-priority knowledge gap identified by Workshop participants was
the need to better understand the role of circadian rhythms and sleep in adaptive immune responses. While
there has been an intense focus on how clocks regulate innate immunity, research into the mechanisms
connecting circadian and sleep disruption to adaptive immune functions remains sparse. This is partly due
to early skepticism that something as short as a 24-hour clock could be relevant to antigen-specific B and T
cell responses, which form over days to weeks. Results from prior experiments in mice with T cell–specific
Bmal1 deletion were interpreted to mean that circadian clocks have little influence over adaptive immune
activities (96). However, some of these earlier experiments did not factor time of day into the experimental
design, and subsequent studies that controlled for this variable did report circadian effects in outcomes such
as autoimmune pathology (56, 65). Moreover, T cell proliferation in response to antigen displays a circadian rhythm in mice that is clock dependent (97). In other research, time of day and sleep quantity were both
shown to impact markers of vaccine efficacy in humans and rodents (44, 74, 75, 97–99). Clocks may also
affect adaptive immunity via control of immune checkpoints, as disruption of circadian rhythms in rodents
appears to exacerbate bacterial peritonitis in part by increasing programmed cell death ligand 1 (PD-L1)
expression on macrophages, which represses T cell activities (100). With this background, Workshop participants identified a critical need to elucidate how circadian clocks mediate various aspects of specific
immunity. The potential clinical ramifications of such research are very broad, including, but not limited
to, the treatment of autoimmunity (101), long-term preservation of organ function in transplanted organs
insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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such as the lung (102, 103), cancer immunotherapy (104–106), establishment of allergic tolerance (107),
“immune paralysis” that accompanies severe sepsis (100, 108), and even age-related changes in immune
function (109, 110). A specific opportunity with high potential impact for public health is to achieve a better
understanding of how the timing of immunization might influence the molecular and cellular processes
underlying the establishment of protective immunity. Such research could find application in improving
existing immunization programs in the elderly and, importantly, in targeting diseases deemed to be difficult
targets for vaccination, such as malaria (111–114).
Neuroinflammatory mechanisms. Examination of neuroinflammatory mechanisms as a link by which
circadian rhythms and sleep affect immunity was identified as another topic of interest. It is increasingly
appreciated that the nervous system and immune system share common mediators. For example, Th2 cytokines, such as IL-4 and IL-13, figure prominently in the pathogenesis of allergy and asthma but also serve
as neurotransmitters within the peripheral nervous system, where they mediate itch (115, 116). Acetylcholine is a classic neurotransmitter of the CNS and the autonomic nervous system but is also secreted by a
subpopulation of peripheral T cells (117, 118). Importantly, chronic itch has a strong nocturnal predominance, and autonomic tone has a prominent circadian rhythm (51, 119). Moreover, clock gene deletion
appears to exacerbate neurodegenerative disease in experimental models in part by inducing inflammatory
responses in astrocytes (120, 121). Conversely, neurodegenerative diseases are accompanied by coincident
disturbances in sleep and circadian activity patterns, implying a bidirectional relationship (122). Exploring
potential circadian and sleep influences on neuroimmune pathways inside and outside the CNS could
translate into new therapeutic approaches for a wide variety of human diseases. One opportunity cited by
Workshop participants was to better understand how circadian rhythms in autonomic tone contribute to
neuroimmune reflexes, such as those that influence sepsis outcomes (123, 124). Results of such research
could find application in the treatment of critical illnesses such as sepsis and pneumonia potentially by
targeting the molecular clock and its downstream effectors, or by optimally timing interventions that target
the inflammatory reflex. Another potential application is targeting the clock to reduce neuroinflammation
that contributes to Alzheimer’s disease and other neurodegenerative disorders (120–122).
Microbiome and immunity. A third high-impact opportunity identified by Workshop participants is to better
understand interrelationships among circadian rhythms, the microbiome, and immunity. The microbiome
— made up of trillions of microorganisms found throughout the body, with the largest numbers in the small
and large intestines — is unique to each individual and plays a significant role in health and disease. Current
research suggests a complex bidirectional relationship between circadian clocks and the microbiome, which
produces metabolites that modulate innate and adaptive immune responses (125–127). Rodents exhibit daily
rhythms in microbiome mass that are driven by circadian patterns in feeding behavior (128, 129). In turn, normal microbiota are necessary for normal circadian gene expression in the liver (130). Therefore, circadian-mediated release of microbiota-derived metabolites may directly regulate rhythmic immune-related phenotypes.
Rhythmic release of metabolites may also synchronize the body to the external environment, possibly extending to the entrainment of immune cells. One specific opportunity is to elucidate the relationship among the
microbiota, the circadian rhythm, and immune responses, with obvious applications for gastrointestinal disease. Since metabolic and immune responses are often linked, understanding the interplay among the microbiome, the immune system, and circadian rhythms would also be applicable in the treatment of metabolic
syndrome, an important risk factor for both cardiovascular and endocrine diseases (131).
Additionally, the participants encouraged applying circadian and sleep biology to topics for which such
influences are underexplored. Leading these were the fetal origins of adult-onset disease (94), sex-specific
differences in various disease models, substance abuse (132, 133), crosstalk between innate and adaptive
immune cells, and the ability of immune cells to induce physiological changes in nonimmune cells. A recent
study suggested that circadian gene expression in mouse lungs could be reprogrammed by depleting mice of
neutrophils, even though these cells are relatively uncommon in the lung parenchyma (134). It is likely that
there are other examples of immune end-organ crosstalk that may have physiologic or medical significance.

Challenges
Circadian and sleep biology hold considerable promise for the development of immunomodulatory
therapies to combat disease. However, there was agreement among the Workshop participants that
scientific, technical, and cultural challenges must be overcome if chronotherapy is to be applicable in
a general clinical setting.
insight.jci.org   https://doi.org/10.1172/jci.insight.131487
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Scientific challenges. We are living through a great era of molecular genetics, in which the ability to modulate the expression of single genes is transforming the way we understand disease. The discovery of the
molecular circadian clock might never have occurred without genetic screens in Drosophila (7), and sleep
research also benefits from the application of genetics (135). Unquestionably, knockout mice and other
genetic reagents represent important stepping-stones for examining circadian-sleep–immune connections,
but exclusive reliance on genetic approaches in model organisms is not without caveats. While the use
of small molecule modulators should complement genetic approaches, caution should be exercised with
them too. This is due to a combination of factors, including complexity of the immune system, multiple
cell types and peripheral tissues involved, and genetic redundancy in the circadian clock. Thus, exclusive
reliance on either genetic or chemical techniques to infer mechanism can be problematic. Fortunately, there
are diverse ways, including genetic, environmental, and chemical approaches, to interfere with circadian
and sleep research activities (136–139). Overall, the Workshop favored a philosophy of routine orthogonal
validation (i.e., validating conclusions using at least two technically disparate experimental approaches) to
better understand how circadian clocks, sleep, and immunity affect each other.
Technical challenges. One important technical need for facilitating trials incorporating circadian biology
is a quick and robust way of determining the circadian phase of an individual (biological time of day versus
external time). The reason for this is that in developed regions, nearly every individual is at risk of desynchrony due to modern-day infrastructure (i.e., artificial light, social media, irregular sleep-wake schedules,
time zone changes, etc.). This is evident from prospective observations of nurses whose circadian rhythms
in body temperature were shown to be out of phase as much as 3 days after a night shift (140). On the gene
expression level, analyses of human circadian transcriptomes from biopsy samples suggest that about 20%
of the populace is significantly out of phase relative to the majority, perhaps reflecting the prevalence of
shift work in developed countries (141). What this means is that any chronotherapy trial wherein an intervention is pegged to a set time of day must contend with the fact that the internal biological time of patients
involved can be quite different. Future attempts to translate circadian biology to the clinic will need to focus
on ways of defining the circadian phase of each participant in advance so that the therapy is applied at the
optimal time for each individual. To this end, it would be valuable to include a run-in period where sleep
hygiene and uniform circadian entrainment are pursued as a goal before a chronotherapy intervention is
attempted. However, Workshop participants noted that requiring a run-in period for chronotherapy trials
could discourage future research because of the increased cost and study complexity this practice would
incur. Fortunately, recent work on circadian biomarkers suggests that spot analysis of gene expression in
blood samples can determine patients’ internal circadian time, which could potentially offset the need for
a run-in period (142, 143). Similarly, robust and quantifiable biomarkers of sleep debt would greatly facilitate translational circadian rhythm research, as sleep disturbance may mask the immunologic benefits of a
chronotherapy intervention.
Another technical challenge is that circadian amplitudes vary dramatically between individuals (49),
but the significance of this variation is not known. At the gene expression level, all circadian transcriptomes
compiled to date represent average gene expression across a tissue sample or collection of cells. When
the amplitude of clock gene expression is found to be relatively low (as occurs after shift work; ref. 144),
it could mean that clock gene expression has been identically damped in each individual cell, or that the
cellular clocks in the sample have fallen out of phase with one another so that the average of the signals
is low. To decipher the meaning of circadian amplitude changes, profiling of circadian rhythms at the single-cell level will likely be required. To generate high-quality circadian transcriptomes from mammalian
tissue, RNA-sequencing (RNA-Seq) reads on the order of 20–40 million per sample are needed (145), but
current single-cell sequencing technology delivers on the order of thousands of reads per cell. Technical
improvements that extend the reading depth of single-cell RNA-Seq would foster its application to circadian measurements in humans and could greatly speed translational research.
Cultural challenges. In addition to posing scientific and technical challenges, chronobiology runs against
the grain in much of the developed world, which is designed to liberate people from natural biological
rhythms. Many may enjoy the convenience and stimulation offered by the so-called 24-7 society. Nighttime illumination renders streets safer, and in a culture where people consider time a precious commodity,
sleep can be construed as wasteful. Specific to the patient experience, the process of care in hospitals is
designed around the rapid provision of diagnostic services and medical intervention, and thus circadian
rhythms and sleep quality are inevitably disregarded. Nevertheless, biological sleep and consolidated circainsight.jci.org   https://doi.org/10.1172/jci.insight.131487
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dian rhythms are essential for health, and a greater effort to communicate scientific findings to the general
public and the medical community is urgently needed. Ultimately, societies may or may not be prepared
to make changes in, for example, how hospitals are run or the adoption of time-release drug preparations
that are more expensive in the short term but confer superior medical and economic utility in the long term
(146). Regardless of these meta-issues, small innovations can yield significant benefits. For example, simply recording the times immunologic assays are conducted may improve the reproducibility of preclinical
research in some circumstances, even when circadian rhythms are not the intended focus of study (34, 147).
Another recommendation raised by Workshop participants was to modify preclinical toxicology studies
such that new investigational drugs are dosed at different times of day. This might help reduce side effects
in phase I clinical trials, leading to a more streamlined approval process.

Conclusion
Emerging intersectional research on sleep, circadian rhythms, and immunity presents exciting opportunities for using scientific understanding to augment the immune resilience of shift workers and other at-risk,
but otherwise healthy, personnel, while at the same time mitigating the burden of major inflammatory
diseases. A better understanding of how the immune system utilizes time as a biological variable could
engender the development of new immunomodulatory therapies and the timing of administration of therapies, all of which may help improve the efficacy of existing drugs. A deeper understanding may also aid in
the development of regimens to maximize vaccine efficacy, combat infections, and optimize time of organ
transplant to minimize rejection. While connections to adaptive immunity and neuroinflammatory reflexes
represent some highly opportune areas for study in the present, there are many areas of disease physiology
for which the insights of circadian and sleep biology have yet to be considered. We may discover that circadian rhythms are an essential clinical element that must be factored into health and prevention efforts, as
well as the diagnosis and therapeutics of disease.
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